Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice.
about
Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usageDNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier stateCharacterization of humoral and CD4+ cellular responses after genetic immunization with retroviral vectors expressing different forms of the hepatitis B virus core and e antigensIntracellular retention of hepatitis B virus surface proteins reduces interleukin-2 augmentation after genetic immunizationsProtective efficacy of DNA vaccines against duck hepatitis B virus infection.Prevention of adult T-cell leukemia-like lymphoproliferative disease in rats by adoptively transferred T cells from a donor immunized with human T-cell leukemia virus type 1 Tax-coding DNA vaccine.CpG oligodeoxynucleotides with hepatitis B surface antigen (HBsAg) for vaccination in HBsAg-transgenic mice.Resistance to Coccidioides immitis in mice after immunization with recombinant protein or a DNA vaccine of a proline-rich antigenLack of tumor necrosis factor alpha induces impaired proliferation of hepatitis B virus-specific cytotoxic T lymphocytes.Lentivector expressing HBsAg and immunoglobulin Fc fusion antigen induces potent immune responses and results in seroconversion in HBsAg transgenic mice.DNA immunization confers protection against murine cytomegalovirus infection.Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2.Characterization of CD8+ cytotoxic T-lymphocyte responses after genetic immunization with retrovirus vectors expressing different forms of the hepatitis B virus core and e antigens.Humoral and cellular immunogenecity of DNA vaccine based on hepatitis B core gene in rhesus monkeysDNA-based vaccination induces humoral and cellular immune responses against hepatitis B virus surface antigen in mice without activation of C-myc.Harnessing DNA-induced immune responses for improving cancer vaccines.A DNA vaccine prime followed by a liposome-encapsulated protein boost confers enhanced mucosal immune responses and protectionDNA vaccines for emerging infectious diseases: what if?Novel Woodchuck Hepatitis Virus (WHV) transgene mouse models show sex-dependent WHV replicative activity and development of spontaneous immune responses to WHV proteins.Immunization of woodchucks with plasmids expressing woodchuck hepatitis virus (WHV) core antigen and surface antigen suppresses WHV infection.Protection of mice against lethal coxsackievirus B3 infection by using DNA immunization.In vivo compartmentalization of functionally distinct, rapidly responsive antigen-specific T-cell populations in DNA-immunized or Salmonella enterica serovar Typhimurium-infected mice.Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes.Immunization with the gene expressing woodchuck hepatitis virus nucleocapsid protein fused to cytotoxic-T-lymphocyte-associated antigen 4 leads to enhanced specific immune responses in mice and woodchucks.
P2860
Q24531468-D3C80BD2-915F-46DC-9AFC-EB5E71ED27E0Q24607288-38ECA5FD-D017-444D-91ED-85F38624086AQ24673500-94154F2E-DE32-4797-8A3D-081EC4C19978Q33647974-5EA9AFBC-EB50-4DB0-81A7-A92446416E5DQ33781877-62E6AAA8-6E2F-411A-A1D7-2A51F8C5281FQ33811681-D698EC54-F6FD-49B5-8A28-188AC5144C53Q33843264-AFC69CBC-3B1A-4A1E-AEEA-BCE40EA8B809Q34001129-5EBF9C02-614E-4B57-9665-C4DEE69C3C36Q34471459-639B8EF0-588D-4F1C-8CDC-86F1AA47F5E6Q34958663-E1CA6454-6C14-4153-9EEF-060AED725128Q35872388-31EEFB0A-AAB7-4531-8B63-9C25898C2966Q35874803-7169F917-BE56-4198-90CA-6761452AA66EQ35882104-1581CBD0-A4C4-4438-9470-04789B98B3E9Q36397263-B4E6C25F-38B0-49E2-BD1C-56E1FB5E876EQ36491901-5857B02B-FA1B-48FB-8A02-647CE4E002D1Q36694866-E88B80A5-6306-4C38-BE3D-7521C71CA131Q36787928-1A3527BB-6365-459F-AF3B-5AA292BCCC1BQ37062242-C46D63F4-456F-411A-AB0E-9A0868C6A0EFQ37547342-D5B88FAA-621A-435D-8571-8EF5A95C3FA5Q39548701-61EC7942-E2CA-4C43-9658-61144D25C06AQ39581490-41DD7836-7D38-4575-A432-BF92007D1F71Q40206574-E37B9300-64E0-4CBA-B82D-B27FC1934C9EQ42251440-1F75130D-169F-46A8-9034-E27BE7928DBAQ42732085-9A59832E-FB7B-4880-801B-492DF1CAB45B
P2860
Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Nucleic acid vaccination prime ...... phocytes in nonresponder mice.
@ast
Nucleic acid vaccination prime ...... phocytes in nonresponder mice.
@en
type
label
Nucleic acid vaccination prime ...... phocytes in nonresponder mice.
@ast
Nucleic acid vaccination prime ...... phocytes in nonresponder mice.
@en
prefLabel
Nucleic acid vaccination prime ...... phocytes in nonresponder mice.
@ast
Nucleic acid vaccination prime ...... phocytes in nonresponder mice.
@en
P2093
P2860
P1433
P1476
Nucleic acid vaccination prime ...... mphocytes in nonresponder mice
@en
P2093
P2860
P304
P407
P577
1995-10-01T00:00:00Z